BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

Search

Merck KGaA

Ouvert

121.4 1.42

Résumé

Variation du prix de l'action

24h

Actuel

Min

119.7

Max

122.55

Chiffres clés

By Trading Economics

Revenu

-142M

667M

Ventes

152M

5.4B

P/E

Moyenne du Secteur

26.27

57.333

BPA

2.2

Rendement du dividende

1.34

Marge bénéficiaire

12.311

EBITDA

85M

1.6B

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+38.83% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

1.34%

2.63%

Prochains Résultats

15 mai 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

33B

98B

Ouverture précédente

119.98

Clôture précédente

121.4

Score Technique

By Trading Central

Confiance

Very Strong Bullish Evidence

Merck KGaA Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

6 mars 2025, 06:27 UTC

Résultats

Merck KGaA Forecasts Earnings, Sales Growth After In-Line Results

11 févr. 2025, 07:03 UTC

Acquisitions, Fusions, Rachats

Germany's Merck in Talks to Buy SpringWorks Therapeutics

10 févr. 2025, 16:38 UTC

Principaux Mouvements du Marché
Acquisitions, Fusions, Rachats

SpringWorks Therapeutics Shares Rise on Report it May be Acquired

24 avr. 2025, 22:51 UTC

Actualités
Acquisitions, Fusions, Rachats

Germany's Merck Nears Roughly $3.5 Billion Deal for SpringWorks -- Update

24 avr. 2025, 20:54 UTC

Acquisitions, Fusions, Rachats

Merck KGaA: No Final Decision Has Been Taken; No Legally Binding Agreement Has Been Entered Into

24 avr. 2025, 20:50 UTC

Acquisitions, Fusions, Rachats

Merck KGaA Confirms Late-Stage Discussions With SpringWorks Therapeutics on Potential Acquisition for About 47c a Share

24 avr. 2025, 19:05 UTC

Acquisitions, Fusions, Rachats

Merck KGaA Expected to Pay Close to $47 a Share for SpringWorks, Sources Say -- WSJ

24 avr. 2025, 19:05 UTC

Acquisitions, Fusions, Rachats

Merck KGaA, SpringWorks Deal Expected to Be Finalized as Soon as Monday, Sources Say -- WSJ

24 avr. 2025, 19:05 UTC

Actualités
Acquisitions, Fusions, Rachats

Germany's Merck Nears Roughly $3.5 Billion Deal for SpringWorks -- WSJ

24 avr. 2025, 19:05 UTC

Acquisitions, Fusions, Rachats

Merck KGaA Nears Roughly $3.5 Billion Takeover of SpringWorks Therapeutics, Sources Say -- WSJ

6 mars 2025, 11:18 UTC

Market Talk
Résultats

Impact from U.S. Tariffs Is Manageable for Merck KGaA, CEO Says -- Market Talk

6 mars 2025, 11:14 UTC

Market Talk

Merck KGaA's Outlook Signals Greater Transparency -- Market Talk

6 mars 2025, 08:20 UTC

Market Talk
Résultats

Merck KGaA's Earnings Guidance Seems Soft Amid Semiconductor Uncertainty -- Market Talk

6 mars 2025, 06:00 UTC

Résultats

Merck KGaA Expects 2025 Net Sales Between EUR21.5B and EUR22.9B

6 mars 2025, 06:00 UTC

Résultats

Merck KGaA 2024 Adj EPS EUR8.63

6 mars 2025, 06:00 UTC

Résultats

Merck KGaA Expects 2025 EBITDA Before One-Time Items Between EUR6.1B and EUR6.6B

6 mars 2025, 06:00 UTC

Résultats

Merck KGaA 2024 EBIT EUR3.645B

6 mars 2025, 06:00 UTC

Résultats

Merck KGaA 2024 After-Tax Profit EUR2.79B

6 mars 2025, 06:00 UTC

Résultats

Merck KGaA 2024 Ebitda Before One-Time Items EUR6.07B

6 mars 2025, 06:00 UTC

Résultats

Merck KGaA 2024 EBITDA EUR5.78B

6 mars 2025, 06:00 UTC

Résultats

Merck KGaA 2024 Sales EUR21.16B

6 mars 2025, 06:00 UTC

Résultats

Merck KGaA Keeps Dividend at EUR2.20

6 mars 2025, 06:00 UTC

Résultats

Analysts Saw Merck KGaA 2024 Sales at EUR21.14B

6 mars 2025, 06:00 UTC

Résultats

Analysts Saw Merck KGaA 2024 Ebitda Before One-Time Items at EUR6.08B

11 févr. 2025, 16:45 UTC

Market Talk
Acquisitions, Fusions, Rachats

Merck's Potential Springworks Deal Unlikely to Move Needle on Earnings -- Market Talk

11 févr. 2025, 10:54 UTC

Market Talk
Acquisitions, Fusions, Rachats

Germany's Merck Potential Buy of SpringWorks Therapeutics Puts Its Strategy Into Question -- Market Talk

11 févr. 2025, 10:52 UTC

Market Talk
Acquisitions, Fusions, Rachats

German Merck's Potential Buy of SpringWorks Therapeutics Holds Profitability Risk -- Market Talk

6 janv. 2025, 13:08 UTC

Acquisitions, Fusions, Rachats

Merck KGaA: Transaction closed on Dec. 23, 2024

6 janv. 2025, 13:07 UTC

Acquisitions, Fusions, Rachats

Merck KGaA: Didn't Disclose Financial Details

6 janv. 2025, 13:06 UTC

Acquisitions, Fusions, Rachats

Merck KGaA: HUB's Organoid Offering Complements Merck KGaA's Cell Culture Portfolio

Comparaison

Variation de prix

Merck KGaA prévision

Objectif de Prix

By TipRanks

38.83% hausse

Prévisions sur 12 Mois

Moyen 166.25 EUR  38.83%

Haut 190 EUR

Bas 107 EUR

Basé sur 9 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

9 ratings

6

Achat

2

Maintien

1

Vente

Score Technique

By Trading Central

117.55 / 120.4Support & Résistance

Court Terme

Very Strong Bullish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Bearish Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Merck KGaA

There is no Profile data available for MRK.BE.